{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:38:20Z","timestamp":1792723100434,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neurot.2026.e01088","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:54:03Z","timestamp":1790790843000},"page":"e01088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CCR5 protects against permanent brain ischemia by suppressing neuronal ferroptosis through AMPK\/ACC signaling"],"prefix":"10.1016","volume":"23","author":[{"given":"Minhuang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suning","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.neurot.2026.e01088_bib1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","year":"2024","journal-title":"Lancet Neurol"},{"issue":"10244","key":"10.1016\/j.neurot.2026.e01088_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(20)31179-X","article-title":"Stroke","volume":"396","author":"Campbell","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.neurot.2026.e01088_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","article-title":"Pathobiology of ischaemic stroke: an integrated view","volume":"22","author":"Dirnagl","year":"1999","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurot.2026.e01088_bib4","doi-asserted-by":"crossref","DOI":"10.2147\/IJGM.S605531","article-title":"Targeting ferroptosis for cerebral neuroprotection in ischemic stroke: pathophysiological insights","volume":"19","author":"Song","year":"2026","journal-title":"Int J Gen Med"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01088_bib5","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01088_bib6","article-title":"Nrf2\/SLC7A11\/GPX4 pathway, a potential target of oridonin in inhibiting ferroptosis during cerebral ischemia-reperfusion injury progression","volume":"16","author":"Zhang","year":"2026","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01088_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90777","article-title":"Inhibition of neuronal ferroptosis protects hemorrhagic brain","volume":"2","author":"Li","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01088_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/0271678X211026770","article-title":"Single-cell RNA-seq reveals the transcriptional landscape in ischemic stroke","volume":"42","author":"Zheng","year":"2022","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01088_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","article-title":"The neurovascular unit coming of Age: a journey through neurovascular coupling in health and disease","volume":"96","author":"Iadecola","year":"2017","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01088_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","article-title":"Neuroinflammation: friend and foe for ischemic stroke","volume":"16","author":"Jayaraj","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01088_bib11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2019.01.044","article-title":"CCR5 is a therapeutic target for recovery after stroke and traumatic brain injury","volume":"176","author":"Joy","year":"2019","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01088_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006387","article-title":"C-C chemokine receptor type 5 (CCR5)-Mediated docking of transferred tregs protects against early blood-brain barrier disruption after stroke","volume":"6","author":"Li","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01088_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.14336\/AD.2020.0406","article-title":"Brain-derived CCR5 contributes to neuroprotection and brain repair after experimental stroke","volume":"12","author":"Ping","year":"2021","journal-title":"Aging Dis"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01088_bib14","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1038\/s41401-023-01100-y","article-title":"A novel small-molecular CCR5 antagonist promotes neural repair after stroke","volume":"44","author":"Wu","year":"2023","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01088_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1476-5381.2010.00697.x","article-title":"Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5","volume":"160","author":"Sorce","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01088_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.neurot.2026.e01088_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn1408","article-title":"HIF1 and oxygen sensing in the brain","volume":"5","author":"Sharp","year":"2004","journal-title":"Nat Rev Neurosci"},{"issue":"18","key":"10.1016\/j.neurot.2026.e01088_bib18","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1016\/j.molcel.2021.08.015","article-title":"AMPK: restoring metabolic homeostasis over space and time","volume":"81","author":"Trefts","year":"2021","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01088_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","article-title":"Energy-stress-mediated AMPK activation inhibits ferroptosis","volume":"22","author":"Lee","year":"2020","journal-title":"Nat Cell Biol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e01088_bib20","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s10571-022-01312-6","article-title":"Activated AMPK protects against chronic cerebral ischemia in bilateral carotid artery stenosis mice","volume":"43","author":"Xie","year":"2023","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01088_bib21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jat.3749","article-title":"The use of cobalt chloride as a chemical hypoxia model","volume":"39","author":"Mu\u00f1oz-S\u00e1nchez","year":"2019","journal-title":"J Appl Toxicol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e01088_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/pathophysiology33030043","article-title":"A differentiated SH-SY5Y model of hypoxic-ischaemic injury reveals dynamic transcriptomic responses during reoxygenation","volume":"33","author":"Salaudeen","year":"2026","journal-title":"Pathophysiology"},{"key":"10.1016\/j.neurot.2026.e01088_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2020.11.037","article-title":"Insight into the roles of CCR5 in learning and memory in normal and disordered states","volume":"92","author":"Necula","year":"2021","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neurot.2026.e01088_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.103245.3","article-title":"Preclinical systematic review of CCR5 antagonists as cerebroprotective and stroke recovery enhancing agents","volume":"14","author":"Sharif","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.neurot.2026.e01088_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2026.120640","article-title":"Silencing CCL5 suppresses ferroptosis to alleviate calcific aortic valve disease through chemokine pathway inhibition","volume":"414","author":"Zhang","year":"2026","journal-title":"Atherosclerosis"},{"issue":"27","key":"10.1016\/j.neurot.2026.e01088_bib26","article-title":"CXCL6 reshapes lipid metabolism and induces neutrophil extracellular trap formation in cholangiocarcinoma progression and immunotherapy resistance","volume":"12","author":"He","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01088_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1538\/expanim.23-0113","article-title":"CCR2 antagonist attenuates calcium oxalate-induced kidney oxidative stress and inflammation by regulating macrophage activation","volume":"73","author":"Wang","year":"2024","journal-title":"Exp Anim"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01088_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s11658-024-00653-y","article-title":"Chemokine CXCL13-CXCR5 signaling in neuroinflammation and pathogenesis of chronic pain and neurological diseases","volume":"29","author":"Zheng","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.neurot.2026.e01088_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175857","article-title":"Dual effect of C-C motif chemokine receptor 5 on ischemic stroke: more harm than benefit?","volume":"953","author":"Jing","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurot.2026.e01088_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntt.2025.107434","article-title":"Dl-3-n-butylphthalein inhibits neuronal apoptosis and ferroptosis after cerebral ischemia-reperfusion injury in rats by regulating CXCR4","volume":"108","author":"Xu","year":"2025","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.neurot.2026.e01088_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1623485","article-title":"Ferroptosis in ischemic stroke: mechanisms, pathological implications, and therapeutic strategies","volume":"19","author":"Long","year":"2025","journal-title":"Front Neurosci"},{"issue":"16","key":"10.1016\/j.neurot.2026.e01088_bib32","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.7150\/thno.25674","article-title":"AMPK: potential therapeutic target for ischemic stroke","volume":"8","author":"Jiang","year":"2018","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.neurot.2026.e01088_bib34","article-title":"Energy stress inhibits ferroptosis via AMPK","volume":"7","author":"Lee","year":"2020","journal-title":"Mol Cell Oncol"},{"key":"10.1016\/j.neurot.2026.e01088_bib33","article-title":"Ferroptosis inhibition and AMPK activation: key mechanisms of soy isoflavones against cerebral injury","volume":"17","author":"Wu","year":"2026","journal-title":"Front Immunol"},{"issue":"16-18","key":"10.1016\/j.neurot.2026.e01088_bib35","doi-asserted-by":"crossref","first-page":"e1173","DOI":"10.1089\/ars.2022.0013","article-title":"The role of AMP-activated protein kinase in oxytosis\/ferroptosis: protector or potentiator?","volume":"41","author":"Currais","year":"2024","journal-title":"Antioxid Redox Signal"},{"issue":"9","key":"10.1016\/j.neurot.2026.e01088_bib36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/jir.2018.0061","article-title":"Metformin inhibits chemokine expression through the AMPK\/NF-\u03baB signaling pathway","volume":"38","author":"Ye","year":"2018","journal-title":"J Interferon Cytokine Res"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01088_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:54:39Z","timestamp":1792720479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926002588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1878747926002588"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01088","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CCR5 protects against permanent brain ischemia by suppressing neuronal ferroptosis through AMPK\/ACC signaling","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e01088"}}